Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 1 / 5 Announcement Summary Entity name ARGENT BIOPHARMA LIMITED Announcement Type New announcement Date of this announcement Monday August 03, 2026 Details of +securities that have...
Notification of cessation of securities - RGT
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Argent Biopharma Ltd has filed a notification regarding the cessation of certain securities, specifically options that have expired. The filing details the expiry of options that were convertible securities without exercise or conversion. Following this cessation, the company's issued capital will reflect the changes in its securities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Argent Biopharma
- CannEpil Global Licence Expands into Veterinary Healthcare
- Quarterly Activities/Appendix 4C Cash Flow Report
- RGT Executes Global CannEpil Licensing Deal for US$5.5M
- Half Yearly Report and Accounts
- Provisional Patent Lodged with USPTO for NanoBodies Platform
Later from Argent Biopharma
- US Veterinary Development Programme for CannEpil Commences
- $250,000 in Funding Received under Financing Facility
- Proposed issue of securities - RGT
- FDA-CVM Establish INAD File for CannEpil Veterinary Program
- Appendix 4G and Corporate Governance Statement
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma